Canada markets close in 5 hours 19 minutes

PharmaTher Holdings Ltd. (PHRM.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.1850-0.0250 (-11.90%)
As of 10:12AM EST. Market open.
Full screen
Previous Close0.2100
Open0.2000
Bid0.1900 x N/A
Ask0.1950 x N/A
Day's Range0.1850 - 0.2200
52 Week Range0.0800 - 0.3400
Volume40,800
Avg. Volume71,356
Market Cap16.311M
Beta (5Y Monthly)3.04
PE Ratio (TTM)N/A
EPS (TTM)-0.0500
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    PharmaTher’s Sairiyo Therapeutics Inc. Advances Clinical Development of Patented Reformulated Cepharanthine for Phase 1 Study in Australia

    TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, announced today Sairiyo Therapeutics Inc. (“Sairiyo”), a company that is forty-nine percent (49%) owned by PharmaTher and fifty-one percent (51%) owned by PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug”), has initiated its regulatory and clinical development plan to evaluate Sairiyo’s patented reformulated enteric coated v

  • GlobeNewswire

    PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine

    TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, provides an update of its Priority Original Abbreviated New Drug Application (“ANDA”) for Ketamine that was accepted by the U.S. Food and Drug Administration (the “FDA”) and assigned a Generic Drug User Fee Amendments of 2022 (“GDUFA”) goal date of April 29, 2024. The ANDA continues to be under review by the FDA and has provided preli

  • Market Exclusive

    Weekly Roundup on the Cannabis Sector & Psychedelic Sector

    Key Takeaways; Cannabis Sector Key Takeaways; Psychedelic Sector Two weeks into the new year, the cannabis sector is buzzing with anticipation as a recent unredacted exchange among federal authorities revealed a compelling catalyst for a potential rally. The released documents from the Health and Human Services disclosed that federal scientists are recommending the removal of […]